802-236-8650 info@medscope.com
Commercial Operations
- LentiVector Development
- Commercial Scale Up
- Cell Line Development/
- Cell Line Mnftr
- Continuous Manufacturing
- Process Analytics (PAT)
- DOE, Multivariate Design
- Scale-Up,-Out,-Down
- Development Protocols
- Equipment
- Single Use
- Strategic De-risk
Regulatory Science
- CMC Development
- Comparability Studies
- Device Design Controls
Analytical Development
- Bioanalytic Assays
- Immuno/PK
- Product/Impurity
- Single Use
- Extractables/Leachables
Medical
- CMO/Med Affairs
- Preclinical Development
- Clinical Development
- CMC Development
- Commercial Manufacture
- Strategic Planning
- Rare Disease
- Pediatric
- Breakthrough Therapies
Manufacturing and ComOps
- Capital Equipment
- BSL-2, ISO7
- Closed Manufacturing
- Suppliers
-Tech Transfer
Facilities & Locations
- 100,00ft2 Manftr/Lab Space
- 50,000 ft2 Office Space
- Cambridge, MA
- Burlington, VT
Quality
- Documentation
- WIFI Controls
- QBD, SOP
- WIFI, BPR, Protocols,
- Audits, PAI,
Sales & Marketing
- Global Strategic Pricing
- General Management
- Strategic Planning
- Market Planning
-Alliance Management
Political Advocacy, Gene Therapy
- Gene Therapy Cost Models
- FDA Realignement
- Workforce Expansion
- Workforce Development
- Regs Patient Bedside Mnftr
U.S. Defense
- Biologics Rapid Monitor
- Biolgogics Rapid Detect
- Biologics Rapid Response
- DARPA, SBIR
Computation
- Protein/DNA Modelling
- Process Capability
- Remote RT View OPC/OLE